Related Experiment Video
Updated: Jul 14, 2026
11:54
Real-Time Proxy-Control of Re-Parameterized Peripheral Signals using a Close-Loop Interface
Published on: May 8, 2021
Cdt1 interactions in the licensing process: a model for dynamic spatiotemporal control of licensing
Georgia Xouri1, Maria Dimaki, Philippe I H Bastiaens
1Laboratory of General Biology, School of Medicine, University of Patras, Patras, Greece.
Cell Cycle (Georgetown, Tex.)
|June 30, 2007
Summary
Cells prevent DNA replication reinitiation using Cdt1 (cell division cycle 1 protein) regulation. Dynamic Cdt1-chromatin interactions and Geminin recruitment ensure proper DNA replication licensing, controlling origin firing in time and space.
Area of Science:
- Cell Biology
- Molecular Biology
- Genetics
Background:
- Cell cycle progression requires precise coordination of DNA replication licensing and initiation.
- Preventing re-replication within a single cell cycle is crucial for genomic stability.
- Cdt1 (cell division cycle 1 protein) and Geminin are key regulators of DNA replication licensing.
Purpose of the Study:
- To discuss the dynamic Cdt1-chromatin interactions.
- To explain the spatial and temporal control of DNA replication licensing.
- To elucidate the role of Geminin recruitment by Cdt1 in preventing re-replication.
Main Methods:
- In vivo chromatin association studies.
- Analysis of Cdt1 and Geminin interactions.
- Discussion of existing literature on cell cycle regulation and DNA replication.
Main Results:
- Cdt1 dynamically associates with chromatin.
- Cdt1 recruits its inhibitor Geminin onto chromatin in vivo.
- These interactions provide spatial and temporal control over replication origin licensing.
Conclusions:
- Dynamic Cdt1-chromatin interactions are essential for regulating DNA replication licensing.
- Local recruitment of Geminin by Cdt1 ensures precise control of origin firing.
- This mechanism prevents re-replication and maintains genomic integrity during the cell cycle.
Related Concept Videos
01:14Pharmacodynamic Models: Link Model and Systems Pharmacodynamic Model
The link model is a fundamental pharmacokinetic-pharmacodynamic (PK–PD) approach to account for delayed drug responses when the observed effect does not immediately correlate with the drug's plasma concentration peak. This delay is mathematically addressed by introducing an effect compartment concentration, Ce, which is kinetically linked to the plasma concentration, Cp, via a first-order rate constant, ke0. The linkage allows for a more accurate prediction of drug effects over time. A higher...
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
01:07Time-Domain Interpretation of PD Control
Proportional-Derivative (PD) control is a widely used control method in various engineering systems to enhance stability and performance. In a system with only proportional control, common issues include high maximum overshoot and oscillation, observed in both the error signal and its rate of change. This behavior can be divided into three distinct phases: initial overshoot, subsequent undershoot, and gradual stabilization.
Consider the example of control of motor torque. Initially, a positive...
Consider the example of control of motor torque. Initially, a positive...
01:24Properties of DTFT I
In signal processing, Discrete-Time Fourier Transforms (DTFTs) play a critical role in analyzing discrete-time signals in the frequency domain. Various properties of the DTFTs such as linearity, time-shifting, frequency-shifting, time reversal, conjugation, and time scaling help understand and manipulate these signals for different applications.
The linearity property of DTFTs is fundamental. If two discrete-time signals are multiplied by constants a and b respectively, and then combined to...
The linearity property of DTFTs is fundamental. If two discrete-time signals are multiplied by constants a and b respectively, and then combined to...
01:29Pharmacodynamic Models: Direct Effect Model and Indirect Response Model
Pharmacodynamic models are essential tools in understanding the relationship between drug concentrations and their effects on biological systems. By characterizing the dynamics of drug action, these models guide dose selection, optimize therapeutic efficacy, and inform the development of new drugs. Two major classes of pharmacodynamic models include direct effect and indirect response models.Direct Effect ModelsDirect effect models describe the immediate relationship between drug concentration...
01:14Pharmacokinetic–Pharmacodynamic Relationship: Model Components
Pharmacokinetic-pharmacodynamic (PK–PD) modeling is essential in drug development and clinical pharmacology. It provides a quantitative framework to predict drug behavior and response over time. This approach integrates pharmacokinetics (PK), which describes the drug's absorption, distribution, metabolism, and excretion, with pharmacodynamics (PD), which characterizes the drug’s biological effects and mechanisms of action.The disposition kinetics of a drug determine its plasma...